NewsBenzingaGSK’s Velzatinib Receives Japan Orphan Drug Designation For GIST, Supported By StrateGIST 1 Data; Adds To US FDA Fast Track, US, EU ODDs, Phase III Trials Under Way GSK’s Velzatinib Receives Japan Orphan Drug Designation For GIST, Supported By StrateGIST 1 Data; Adds To US FDA Fast Track, US, EU ODDs, Phase III Trials Under Way Benzinga 2026.11.19 07:50 (GMT+0) Open on Benzinga Other news Meta Halts Mark Zuckerberg’s New Share Issuance Plan Amid Investor Lawsuit Alleging CEO Pressured Board to Approve It Sunlands Technology Q3 EPS $0.41 Down From $1.31 YoY, Sales $49.500M Down From $73.472M YoY Anthropic IPO to Mint Thousands of Millionaires, With Seven Founders Becoming $10 Billion-Plus Billionaires Futu Holdings Q3 Sales $852.660M Beat $814.820M Estimate ATRenew Q3 Adj. EPS $0.15 Beats $0.10 Estimate, Sales $962.500M Beat $944.000M Estimate AbbVie, DISCO Pharmaceuticals Team Up On AND-Gated Bispecific Solid Tumor Therapeutics Using DISCOtech Platform; Deal Carries $40M Upfront, Up To $2.5B Milestones
Meta Halts Mark Zuckerberg’s New Share Issuance Plan Amid Investor Lawsuit Alleging CEO Pressured Board to Approve It
Anthropic IPO to Mint Thousands of Millionaires, With Seven Founders Becoming $10 Billion-Plus Billionaires
AbbVie, DISCO Pharmaceuticals Team Up On AND-Gated Bispecific Solid Tumor Therapeutics Using DISCOtech Platform; Deal Carries $40M Upfront, Up To $2.5B Milestones